54
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Efficacy of Diabetic Foot Treatment in a “TOSF” Pattern: A Five-Year Retrospective Study

ORCID Icon, , , , , , , & show all
Pages 1923-1939 | Received 27 Feb 2024, Accepted 23 Apr 2024, Published online: 02 May 2024

References

  • Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabet Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
  • Armstrong DG, Boulton A, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367–2375. doi:10.1056/NEJMra1615439
  • Diabetes Society of Chinese Medical Association, Infectious Disease Society of Chinese Medical Association, Tissue Repair and Regeneration Society of Chinese Medical Association. Chinese guidelines for the prevention and management of diabetic foot (2019 edition). Chin J of Diabetes Mellitus. 2019;11(2):92–108.
  • Jiang Y, Wang X, Xia L, et al. A cohort study of diabetic patients and diabetic foot ulceration patients in China. Wound Repair Regen. 2015;23(2):222–230. doi:10.1111/wrr.12263
  • Huang Y. International Diabetes Federation. 8th ed. IDF Diabetes Atlas; 2017.
  • Huang J, Sun J, Wang Q, et al. A Novel Wound Therapy Modality: autologous Wound Edge Dotted Full-Thickness Skin Grafting Improving Diabetic Foot Ulcer Healing. Int J Gen Med. 2023;16:3815–3827. doi:10.2147/IJGM.S427401
  • Musuuza J, Sutherland BL, Kurter S, et al. A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers. J Vasc Surg. 2020;71(4):1433–1446. doi:10.1016/j.jvs.2019.08.244
  • Ran X, Zhao J. We should strengthen the construction of multidisciplinary team to improve the diagnosis and treatment of diabetic peripheral vascular disease and foot disease. J Sichuan Univ. 2012;43(05):728–733.
  • Dong J, Guo R, Chang W, et al. Exploration and practice: discipline reform based on organ system under the integrated medical model. Chinese Hospital. 2021;25(11):61–63.
  • Yongquan G. Chinese guidelines for the diagnosis and treatment of diabetic foot. Natl Med J China. 2020;48(01):19–27.
  • Xiao T, Wang B. The Impact of Albumin Use Guidelines & Pharmacist Participation in General Surgery Ward: 2010 China Pharmaceutical Congress and the 10th Chinese Pharmacist Week[C], Tianjin, China. Int J Med. 2010.
  • Lipsky BA, Senneville E, Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3280. doi:10.1002/dmrr.3280
  • Michail M, Jude E, Liaskos C, et al. The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis. Int J Low Extrem Wounds. 2013;12(2):94–99. doi:10.1177/1534734613486152
  • Wagner FW. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2(2):64–122. doi:10.1177/107110078100200202
  • Al-Rubeaan K, Al DM, Ouizi S, et al. Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS One. 2015;10(5):e124446. doi:10.1371/journal.pone.0124446
  • Khan N, Sapsed S. Diabetes foot complication: assessing primary and secondary outcomes of multidisciplinary team versus standard care (a systematic review). Int j Diabetes Dev Countries. 2017;37(2). doi:10.1007/s13410-015-0422-0
  • Buggy A, Moore Z. The impact of the multidisciplinary team in the management of individuals with diabetic foot ulcers: a systematic review. J Wound Care. 2017;26(6):324–339. doi:10.12968/jowc.2017.26.6.324
  • Xie Y, Zhao W. Incidence and risk factors of amputation among inpatients with diabetic foot. Community Physicians in China. 2022;38(01):60–62.
  • Winkley K, Stahl D, Chalder T, et al. Risk factors associated with adverse outcomes in a population-based prospective cohort study of people with their first diabetic foot ulcer. J diabet complicat. 2007;21(6):341–349. doi:10.1016/j.jdiacomp.2007.09.004
  • Li X, Xiao T, Wang Y, et al. Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital. Diabet Res Clin Pract. 2011;93(1):26–30. doi:10.1016/j.diabres.2011.03.014
  • Chu YJ, Li XW, Wang PH, et al. Clinical outcomes of toe amputation in patients with type 2 diabetes in Tianjin, China. Int Wound J. 2016;13(2):175–181. doi:10.1111/iwj.12249
  • Wang A, Di Z, Qiang L, et al. A multicenter survey on the diabetic foot and medical economics in China. Chin J Endocrinol Metab. 2005;1(6):496–499.
  • Zhang X, Ran X, Xu Z, et al. Epidemiological characteristics of lower extremity arterial disease in Chinese diabetes patients at high risk: a prospective, multicenter, cross-sectional study. J diabet complicat. 2018;32(2):150. doi:10.1016/j.jdiacomp.2017.10.003
  • Zhang P, Lu J, Jing Y, et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann Med. 2017;49(2):106–116. doi:10.1080/07853890.2016.1231932
  • Gurney JK, Stanley J, York S, et al. Risk of lower limb amputation in a national prevalent cohort of patients with diabetes. Diabetologia. 2018;61(3):626–635. doi:10.1007/s00125-017-4488-8
  • Stancu B, Ilyes T, Farcas M, et al. Diabetic foot complications: a retrospective cohort study. Int J Environ Res Public Health. 2022;20(1). doi:10.3390/ijerph20010187
  • Al-Mahroos F, Al-Roomi K. Diabetic neuropathy, foot ulceration, peripheral vascular disease and potential risk factors among patients with diabetes in Bahrain: a nationwide primary care diabetes clinic-based study. Ann Saudi Med. 2007;27(1):25–31. doi:10.5144/0256-4947.2007.25
  • Bruun C, Siersma V, Guassora AD, et al. Amputations and foot ulcers in patients newly diagnosed with Type2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidity. Diabet Med. 2013;30(8):964–972. doi:10.1111/dme.12196
  • Huang ES, Laiteerapong N, Liu JY, et al. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med. 2014;174(2):251–258. doi:10.1001/jamainternmed.2013.12956
  • Aidin R, Araz R, Stefan F, et al. Risk Factors, Mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379(7):633–644. doi:10.1056/NEJMoa1800256
  • Shen Q, Yun L, Limin L, et al. Sex-specific associations between tobacco and risk of cardiovascular disease in Chinese adults. Chin J Epidemiol. 2018;39(001):8–15.
  • Liu C, Chen L. Diabetes screening and diagnosis with HbA1c. Int J Endocrinol Metab. 2009;29(4):5.
  • Close KL, Marathe PH, Gao HX. American Diabetes Association Standards of Medical Care in Diabetes. Am Diabetes Assoc. 2017:2013:56.
  • Gerstein HC, Pogue J, Mann JF, et al. The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia. 2005;48(9):1749–1755. doi:10.1007/s00125-005-1858-4
  • Dapeng L, Guangwei X. Albumin and surgical nutrition. Chinese J Pract Sur. 2003;2(7):65–66.
  • Hankins J. The role of albumin in fluid and electrolyte balance. J Infus Nurs. 2006;29(5):260–265. doi:10.1097/00129804-200609000-00004
  • Fritz HG, Brandes H, Bredle DL, et al. Post-operative hypoalbuminaemia and procalcitonin elevation for prediction of outcome in cardiopulmonary bypass surgery. Acta Anaesthesiol Scand. 2003;47(10):1276–1283. doi:10.1046/j.1399-6576.2003.00239.x
  • Sedrakyan A, Gondek K, Paltiel D, et al. Volume Expansion With Albumin Decreases Mortality After Coronary Artery Bypass Graft Surgery. Chest. 2003;123(6):1853–1857. doi:10.1378/chest.123.6.1853
  • Diabetes Society of Chinese Medical Association, Infectious Disease Society of Chinese Medical Association, Tissue Repair and Regeneration Society of Chinese Medical Association. Chinese guidelines for the prevention and management of diabetic foot (2019 edition)(II). Chin J of Diabetes Mellitus. 2019;11(2):92–108.
  • Lavery LA, Armstrong DG, Murdoch DP, et al. Validation of the Infectious Diseases Society of America’s diabetic foot infection classification system. Clin Infect Dis. 2007;44(4):562–565. doi:10.1086/511036
  • Diabetes Society of Chinese Medical Association, Infectious Disease Society of Chinese Medical Association, Tissue Repair and Regeneration Society of Chinese Medical Association. Chinese guidelines for the prevention and management of diabetic foot (2019 edition)(III). Chin J Diabetes Mellitus. 2019;11(4):10.
  • Volaco A, Chantelau E, Richter B, et al. Outcome of critical foot ischaemia in longstanding diabetic patients: a retrospective cohort study in a specialised tertiary care centre. J Vascular Dis. 2004;33(1):36–41. doi:10.1024/0301-1526.33.1.36
  • Lipsky BA, Sheehan P, Armstrong DG, et al. Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial. Int Wound J. 2007;4(1):30–38. doi:10.1111/j.1742-481X.2006.00274.x
  • Gardner SE, Hillis SL, Frantz RA. Clinical signs of infection in diabetic foot ulcers with high microbial load. Biol Res Nurs. 2009;11(2):119–128. doi:10.1177/1099800408326169
  • Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care. 1998;21(5):855–859. doi:10.2337/diacare.21.5.855
  • Zheng S, Yao B. Impact of risk factors for recurrence after the first ischemic stroke in adults: a systematic review and meta-analysis. J Clin Neurosci. 2019;60:24–30. doi:10.1016/j.jocn.2018.10.026
  • Morbach S, Furchert H, Groblinghoff U, et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care. 2012;35(10):2021–2027. doi:10.2337/dc12-0200
  • Baubeta FE, Andersson M, Thuresson M, et al. Amputation rates, mortality, and pre-operative comorbidities in patients revascularised for intermittent claudication or critical limb ischaemia: a population based study. Eur J Vasc Endovasc Surg. 2017;54(4):480–486. doi:10.1016/j.ejvs.2017.07.005
  • Wang A, Xu Z, Mu Y, et al. Clinical characteristics and medical costs in patients with diabetic amputation and nondiabetic patients with nonacute amputation in central urban hospitals in China. Int J Low Extrem Wounds. 2014;13(1):17–21. doi:10.1177/1534734614521235
  • Xiao T, Wang A, Zhangrong X, et al. Analysis of amputation risk factors in 436 patients with diabetic foot. Chin J Endocrinol Metab. 2009;6:591–594.
  • Mutirangura P, Ruangsetakit C, Wongwanit C, et al. Comparative study of the management of diabetic versus nondiabetic patients with atherosclerosis obliterans of the lower extremities. Vascular. 2008;16(6):333–339. doi:10.2310/6670.2008.00062
  • Jiang Y, Ran X, Jia L, et al. Epidemiology of type 2 diabetic foot problems and predictive factors for amputation in China. Int J Low Extrem Wounds. 2015;14(1):19–27. doi:10.1177/1534734614564867
  • Brocco E, Ninkovic S, Marin M, et al. Diabetic foot management: multidisciplinary approach for advanced lesion rescue. J Cardiovasc Surg (Torino). 2018;59(5):670–684. doi:10.23736/S0021-9509.18.10606-9
  • Adiewere P, Gillis RB, Imran Jiwani S, et al. A systematic review and meta-analysis of patient education in preventing and reducing the incidence or recurrence of adult diabetes foot ulcers (DFU). Heliyon. 2018;4(5):e614. doi:10.1016/j.heliyon.2018.e00614
  • Brennan MB, Hess TM, Bartle B, et al. Diabetic foot ulcer severity predicts mortality among veterans with type 2 diabetes. J Diabetes Complications. 2017;31(3):556–561. doi:10.1016/j.jdiacomp.2016.11.020
  • Jing C, Qingfeng C. Analysis of risk factors for amputation and mortality in patients with diabetic foot. Chin J Diabetes. 2018;26(02):123–127.
  • Ghanassia E, Villon L, Thuan DDJ, et al. Long-term outcome and disability of diabetic patients hospitalized for diabetic foot ulcers: a 6.5-year follow-up study. Diabetes Care. 2008;31(7):1288–1292. doi:10.2337/dc07-2145
  • Walsh JW, Hoffstad OJ, Sullivan MO, et al. Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet Med. 2016;33(11):1493–1498. doi:10.1111/dme.13054